Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Yohann Loriot

Institut Gustave Roussy

France

Research Interests

Explore related searches

Professors in France Professors in Biostatistics Biostatistics professors in France

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Collaborators (13)

Gwenaelle Gravis

Praticien Hospitalier Spécialiste Oncologie; Head of the onco-urology (since 2001) , Head of the outpatient unit (2002-2018) , Reviewer for the Clinical Research protocol (since 2017)

Institut Paoli-Calmettes

FRANCE

View details

Gunnar Folprecht

Unit Chair Medical Oncology

University Hospital Carl Gustav Carus

GERMANY

View details

Thomas Powles

Professor of Genitourinary Oncology

Queen Mary University of London

UNITED KINGDOM

View details

Birgit Geoerger

Université Paris-Saclay

FRANCE

View details

Victor Moreno

Director

Hospital Universitario Fundación Jiménez Díaz

SPAIN

View details

TAEK WON KANG

Professor

Chonnam National University Medical School

SOUTH KOREA

View details

Bertrand TOMBAL

Chairman

Université catholique de Louvain

BELGIUM

View details

Hans Prenen

Antwerp University Hospital

BELGIUM

View details

Silke Gillessen

Full Professor

The University of Manchester

UNITED KINGDOM

View details

Josep Tabernero

Associate Professor Faculty of Medicine

Universitat de Vic - Universitat Central de Catalunya

SPAIN

View details

Joon Oh Park

Sungkyunkwan University School of Medicine

SOUTH KOREA

View details

Houede Nadine

Professeur des Universités

University of Montpellier

FRANCE

View details

Bradley McGregor

Harvard University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yohann Loriot

Research Interests

Explore related searches

Articles (11)

Erdafitinib in Patients with FGFR-altered Advanced or Metastatic Cholangiocarcinoma

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study

Full enrollment results from cohort 1 of the phase III randomized THOR trial of erdafitinib versus chemotherapy in FGFR-altered advanced urothelial carcinoma

EVOLUTE: Enfortumab Vedotin in OLder patients with locally advanced/metastatic UroThElial carcinoma

Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study

Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts

TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma

COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts

Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial

The next-generation of nectin-4 targeted therapies

Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

Collaborators (13)

Gwenaelle Gravis

Gunnar Folprecht

Thomas Powles

Birgit Geoerger

Victor Moreno

TAEK WON KANG

Bertrand TOMBAL

Hans Prenen

Silke Gillessen

Josep Tabernero

Joon Oh Park

Houede Nadine

Bradley McGregor

Make your next move.